Infection caused by vancomycin-resistant Streptococcus sanguis IISHLAES, D. M; MARINO, J; JACOBS, M. R et al.Antimicrobial agents and chemotherapy. 1984, Vol 25, Num 4, pp 527-528, issn 0066-4804Article

Factors that influence the evolution of β-lactam resistance in β-lactamase-unducible strains of Enterobacter cloacae and Pseudomonas aeruginosaARONOFF, S. C; SHLAES, D. M.The Journal of infectious diseases. 1987, Vol 155, Num 5, pp 936-941, issn 0022-1899Article

Mutations altering substrate specificity in OHIO-, an SHV-I family β-lactamaseSHLAES, D. M; CURRIE-MCCUMBER, C.Biochemical journal (London. 1984). 1992, Vol 284, pp 411-415, issn 0264-6021, 2Article

Physiological characteristics and deoxyribonucleic acid relatedness of Streptococcus intermedius strainsKNIGHT, R. G; SHLAES, D. M.International journal of systematic bacteriology. 1988, Vol 38, Num 1, pp 19-24, issn 0020-7713Article

Physiological characteristics and deoxyribonucleic acid relatedness of human isolates of Streptococcus bovis and Streptococcus bovis (var.)KNIGHT, R. G; SHLAES, D. M.International journal of systematic bacteriology. 1985, Vol 35, Num 3, pp 357-361, issn 0020-7713Article

Endemic gentamicin resistance R factors on a spinal cord injury unitSHLAES, D. M; CURRIE, C. A.Journal of clinical microbiology (Print). 1983, Vol 18, Num 2, pp 236-241, issn 0095-1137Article

Intraabdominal infection : differences in presentation and outcome between younger patients and the elderlyCOOPER, G. S; SHLAES, D. M; SALATA, R. A et al.Clinical infectious diseases. 1994, Vol 19, Num 1, pp 146-148, issn 1058-4838Article

In vivo efficacies of β-lactam-β-lactamase inhibitor combinations against a TEM-26-producing strain of Klebsiella pneumoniaeRICE, L. B; CARIAS, L. L; SHLAES, D. M et al.Antimicrobial agents and chemotherapy. 1994, Vol 38, Num 11, pp 2663-2664, issn 0066-4804Article

Bacteremia due to vancomycin-dependent Enterococcus faeciumGREEN, M; SHLAES, J. H; BARBADORA, K et al.Clinical infectious diseases. 1995, Vol 20, Num 3, pp 712-714, issn 1058-4838Article

OHIO-1 β-lactamase resistant to mechanism-based inactivatorsBONOMO, R. A; CURRIE-MCCUMBER, C; SHLAES, D. M et al.FEMS microbiology letters. 1992, Vol 92, Num 1, pp 79-82, issn 0378-1097Article

Escherichia coli susceptible to glycopeptide antibioticsSHLAES, D. M; SHLAES, J. H; DAVIES, J et al.Antimicrobial agents and chemotherapy. 1989, Vol 33, Num 2, pp 192-197, issn 0066-4804Article

EF-4 Bacteremia in a patient with hepatic carcinoidDUL, M. J; SHLAES, D. M; LERNER, P. I et al.Journal of clinical microbiology (Print). 1983, Vol 18, Num 5, pp 1260-1261, issn 0095-1137Article

Infection caused by thymidine-requiring, trimethoprim-resistant bacteriaKING, C. H; SHLAES, D. M; DUL, M. J et al.Journal of clinical microbiology (Print). 1983, Vol 18, Num 1, pp 79-83, issn 0095-1137Article

Efficacy of ampicillin-sulbactam versus that of cefoxitin for treatment of Escherichia coli infections in a rat intra-abdominal abscess modelRICE, L. B; CARIAS, L. L; SHLAES, D. M et al.Antimicrobial agents and chemotherapy. 1993, Vol 37, Num 3, pp 610-612, issn 0066-4804Article

Streptococcus mitis: a cause of serious infection in adultsCATTO, B. A; JACOBS, M. R; SHLAES, D. M et al.Archives of internal medicine (1960). 1987, Vol 147, Num 5, pp 885-888, issn 0003-9926Article

Vancomycin resistance in the enterococcus. Relevance in pediatricsRICE, L. B; SHLAES, D. M.The Pediatric clinics of North America. 1995, Vol 42, Num 3, pp 601-618, issn 0031-3955Article

Enterobacter bacteremia : clinical features and emergence of antibiotic resistance during therapyCHOW, J. W; FINE, M. J; SHLAES, D. M et al.Annals of internal medicine. 1991, Vol 115, Num 8, pp 585-590, issn 0003-4819Article

Nosocomial clonal dissemination of methicillin-resistant Staphylococcus aureus: elucidation by plasmid analysisRHINEHART, E; SHLAES, D. M; KEYS, T. F et al.Archives of internal medicine (1960). 1987, Vol 147, Num 3, pp 521-524, issn 0003-9926Article

Molecular genetics of resistance to both ceftazidime and β-lactam-β-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to β-lactam therapyRICE, L. B; CARIAS, L. L; BONOMO, R. A et al.The Journal of infectious diseases. 1996, Vol 173, Num 1, pp 151-158, issn 0022-1899Article

Piperacillin/tazobactam compared with ticarcillin/clavulanate in community-acquired bacterial lower respiratory tract infectionSHLAES, D. M; BAUGHMAN, R; WILLIAMS, A et al.Journal of antimicrobial chemotherapy (Print). 1994, Vol 34, Num 4, pp 565-577, issn 0305-7453Article

Teicoplanin-resistant Staphylococcus aureus expresses a novel membrane protein and increases expression of penicillin-binding protein 2 complexSHLAES, D. M; SHLAES, J. H; VINCENT, S et al.Antimicrobial agents and chemotherapy. 1993, Vol 37, Num 11, pp 2432-2437, issn 0066-4804Article

OHIO-1 β-lactamase is part of the SHV-1 familySHLAES, D. M; CURRIER-MCCUMBER, C; HULL, A et al.Antimicrobial agents and chemotherapy. 1990, Vol 34, Num 8, pp 1570-1576, issn 0066-4804, 7 p.Article

Inducible, transferable resistance to vancomycin in Enterococcus faecium, D399SHLAES, D. M; AL-OBEID, S; SHLAES, J. H et al.Journal of antimicrobial chemotherapy (Print). 1989, Vol 23, Num 4, pp 503-508, issn 0305-7453Article

Comparative activities of the β-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined β-lactamase-producing aerobic gram-negative BacilliJACOBS, M. R; ARONOFF, S. C; JOHENNING, S et al.Antimicrobial agents and chemotherapy. 1986, Vol 29, Num 6, pp 980-985, issn 0066-4804Article

Page / 2